C92.Z1
Other myeloid leukemia, in remission
Clinical Classification Guidelines
Medical Intelligence & Overview
Other myeloid leukemia in remission, coded as C92.Z1 in the ICD-10 classification, refers to a stage where a person diagnosed with this type of leukemia has shown no signs of active disease after treatment. This condition indicates that the leukemia cells are not currently detectable, but there remains a possibility of relapse. It is a significant phase in the management of myeloid leukemia, highlighting the importance of ongoing monitoring and care.
Causes & Symptoms
Clinical Causes: Previous diagnosis of myeloid leukemia (such as acute myeloid leukemia or other types involving myeloid cells) Treatment with chemotherapy or other targeted therapies aimed at eradicating leukemia cells Biological factors influencing remission, including immune response and genetic factors
Key Symptoms: Typically, there are no specific symptoms during remission Potential signs of recurrence if leukemia becomes active again, including fatigue, unexplained fever, easy bruising or bleeding, and frequent infections
Diagnostic & Treatment
Diagnosis Path: Remission status is confirmed through various diagnostic tests:
Treatment Protocols: While remission indicates that the disease is not currently active, ongoing management may include:
Clinical Advice & FAQs
Billing Guidance
Is C92.Z1 a billable ICD-10 code?
Yes, C92.Z1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C92.Z1?
Clinical documentation must specify the nature of Other myeloid leukemia, in remission and any associated comorbidities for accurate reporting.
Cite this Clinical Reference